These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 35131312)

  • 1. Gamma delta (γδ) T cells in cancer immunotherapy; where it comes from, where it will go?
    Deng J; Yin H
    Eur J Pharmacol; 2022 Mar; 919():174803. PubMed ID: 35131312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering the Bridge between Innate and Adaptive Immunity for Cancer Immunotherapy: Focus on γδ T and NK Cells.
    Morandi F; Yazdanifar M; Cocco C; Bertaina A; Airoldi I
    Cells; 2020 Jul; 9(8):. PubMed ID: 32707982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advancements in γδT cell engineering: paving the way for enhanced cancer immunotherapy.
    Yuan M; Wang W; Hawes I; Han J; Yao Z; Bertaina A
    Front Immunol; 2024; 15():1360237. PubMed ID: 38576617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translating gammadelta (γδ) T cells and their receptors into cancer cell therapies.
    Sebestyen Z; Prinz I; Déchanet-Merville J; Silva-Santos B; Kuball J
    Nat Rev Drug Discov; 2020 Mar; 19(3):169-184. PubMed ID: 31492944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Human γδ T Cells in Anti-Tumor Immunity and Their Potential for Cancer Immunotherapy.
    Liu Y; Zhang C
    Cells; 2020 May; 9(5):. PubMed ID: 32413966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Generation of Human γδT Cell-Derived Induced Pluripotent Stem Cells from Whole Peripheral Blood Mononuclear Cell Culture.
    Watanabe D; Koyanagi-Aoi M; Taniguchi-Ikeda M; Yoshida Y; Azuma T; Aoi T
    Stem Cells Transl Med; 2018 Jan; 7(1):34-44. PubMed ID: 29164800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Dual Roles of Human γδ T Cells: Anti-Tumor or Tumor-Promoting.
    Li Y; Li G; Zhang J; Wu X; Chen X
    Front Immunol; 2020; 11():619954. PubMed ID: 33664732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Research progress of gammadelta T cell-based immunotherapy].
    Qiu FM; Li ZP; Huang J
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2010 Jul; 39(4):424-9. PubMed ID: 20731045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A close look at current γδ T-cell immunotherapy.
    Ma L; Feng Y; Zhou Z
    Front Immunol; 2023; 14():1140623. PubMed ID: 37063836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the common gamma-chain family cytokines in γδ T cell-based anti-cancer immunotherapy.
    Van Acker HH; Campillo-Davo D; Roex G; Versteven M; Smits EL; Van Tendeloo VF
    Cytokine Growth Factor Rev; 2018 Jun; 41():54-64. PubMed ID: 29773448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. γδ T cells in cancer immunotherapy.
    Zou C; Zhao P; Xiao Z; Han X; Fu F; Fu L
    Oncotarget; 2017 Jan; 8(5):8900-8909. PubMed ID: 27823972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Cytokine Signals to Enhance γδT Cell-Based Cancer Immunotherapy.
    Song Y; Liu Y; Teo HY; Liu H
    Front Immunol; 2022; 13():914839. PubMed ID: 35747139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dichotomous and stable gamma delta T-cell number and function in healthy individuals.
    Ou L; Wang H; Liu Q; Zhang J; Lu H; Luo L; Shi C; Lin S; Dong L; Guo Y; Huang L; Zhu J; Yin X; Huang AC; Karakousis G; Schuchter L; Amaravadi R; Zheng C; Fan Y; Guo W; Xu X
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34011536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CAR-Based Strategies beyond T Lymphocytes: Integrative Opportunities for Cancer Adoptive Immunotherapy.
    Rotolo R; Leuci V; Donini C; Cykowska A; Gammaitoni L; Medico G; Valabrega G; Aglietta M; Sangiolo D
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31212634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. γδ cell-based immunotherapy for cancer.
    Lo Presti E; Corsale AM; Dieli F; Meraviglia S
    Expert Opin Biol Ther; 2019 Sep; 19(9):887-895. PubMed ID: 31220420
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of gamma delta T lymphocytes in breast cancer: a review.
    Morrow ES; Roseweir A; Edwards J
    Transl Res; 2019 Jan; 203():88-96. PubMed ID: 30194922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. γδT Cells and Related Diseases.
    Lu H; Li DJ; Jin LP
    Am J Reprod Immunol; 2016 Jun; 75(6):609-18. PubMed ID: 26833725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent Bidirectional Cross-Talk Between Plasmacytoid Dendritic Cells and γδT Cells Through BTN3A, Type I/II IFNs and Immune Checkpoints.
    Girard P; Ponsard B; Charles J; Chaperot L; Aspord C
    Front Immunol; 2020; 11():861. PubMed ID: 32435249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. γδ T-cell immunotherapy for lung cancer.
    Yoshida Y; Nakajima J; Wada H; Kakimi K
    Surg Today; 2011 May; 41(5):606-11. PubMed ID: 21533930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive & Negative Roles of Innate Effector Cells in Controlling Cancer Progression.
    Stolk D; van der Vliet HJ; de Gruijl TD; van Kooyk Y; Exley MA
    Front Immunol; 2018; 9():1990. PubMed ID: 30298063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.